Multiple Myeloma Case Developed During the Use of the Teriparatide

• Main Authors: Zehra Erdemir (Author), Ayşe İyiyapıcı Ünübol (Author), Mustafa Ünübol (Author), Esra Ercan Aktekin (Author), İrfan Yavaşoğlu (Author), Engin Güney (Author)
• Format: Book
• Published: Galenos Yayinevi, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Recombinant human parathyroid hormone (1-34) (rhPTH 1-34), teriparatide, is a class of anabolic therapy for treating severe osteoporosis. Although plasma cell dyscrasias are excluded among the known side effects of teriparatide treatment, their association in the form of case reports has been report...